Sophie Fougeray Selected Research

O-acetyl-GD2 ganglioside

1/2017

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Fougeray Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 07/2016
2	Glioma (Gliomas) 01/2020 - 07/2016
2	Inflammation (Inflammations) 01/2015 - 01/2014
1	Neuroblastoma 01/2022
1	Neuralgia (Stump Neuralgia) 01/2017
1	Hypoxia (Hypoxemia) 04/2012
1	Juvenile gout 01/2012
1	Hyperuricemia 01/2012
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2012

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 01/2022 - 07/2016
3	AntigensIBA 10/2021 - 07/2016
2	GD2 gangliosideIBA 01/2020 - 07/2016
1	Chimeric Antigen ReceptorsIBA 10/2021
1	NestinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	O-acetyl-GD2 gangliosideIBA 01/2017
1	dinutuximabIBA 01/2017
1	GangliosidesIBA 01/2017
1	GlycolipidsIBA 01/2017
1	InflammasomesIBA 01/2015
1	Protein AggregatesIBA 01/2015
1	hemozoinIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 04/2012
1	UromodulinIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
3	Immunotherapy 01/2022 - 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021